Robaxin: Targeted Muscle Spasm Relief with Methocarbamol
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $2.26 | $80.33 $45.18 (44%) | 🛒 Add to cart |
| 30 | $1.67 | $120.49 $50.20 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $240.98 $55.22 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $361.47 $60.25 (83%) | 🛒 Add to cart |
| 120 | $0.59 | $481.96 $70.29 (85%) | 🛒 Add to cart |
| 180 | $0.50 | $722.94 $90.37 (88%) | 🛒 Add to cart |
| 270 | $0.45 | $1084.41 $120.49 (89%) | 🛒 Add to cart |
| 360 | $0.42
Best per pill | $1445.88 $150.61 (90%) | 🛒 Add to cart |
Synonyms | |||
Robaxin (methocarbamol) is a centrally acting skeletal muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. It works by depressing polysynaptic and monosynaptic transmission within the spinal cord and brainstem, leading to a reduction in skeletal muscle hyperactivity and spasm without directly affecting skeletal muscle fibers or the neuromuscular junction. This mechanism provides significant symptomatic relief, allowing for improved mobility and facilitating the recovery process. Its clinical profile is characterized by a well-established efficacy and a generally favorable tolerability when used appropriately under medical supervision.
Features
- Active Pharmaceutical Ingredient: Methocarbamol.
- Available in 500 mg and 750 mg oral tablets.
- Also available in injectable form for hospital or clinical use (Robaxin Injectable).
- Onset of action for the oral formulation is typically within 30 minutes.
- Peak plasma concentrations are reached approximately 2 hours after an oral dose.
- The elimination half-life is 1 to 2 hours.
- Metabolized in the liver via dealkylation and hydroxylation.
- Excreted primarily in the urine as metabolites and unchanged drug.
Benefits
- Provides rapid relief from acute musculoskeletal pain and spasm, facilitating a quicker return to normal function.
- Reduces muscle hypertonicity, allowing for greater range of motion and participation in physical therapy.
- Acts as an adjunct therapy, enhancing the effects of rest, heat, and other physical modalities.
- Offers a non-opioid option for managing painful muscle conditions, potentially reducing the need for narcotic analgesics.
- Its mechanism of action is central, not peripheral, meaning it does not cause direct muscle weakness at therapeutic doses.
- Well-documented history of safe and effective use in clinical practice for decades.
Common use
Robaxin is commonly prescribed for the management of acute, painful musculoskeletal conditions. This includes, but is not limited to, muscle strains and sprains, low back pain (lumbago), torticollis (wryneck), and myofascial pain syndromes. It is specifically indicated as an adjunct to rest and physical therapy. Its use is typically short-term, focusing on the acute phase of injury to break the cycle of pain-spasm-pain. It is not intended for the treatment of spasticity associated with chronic neurological disorders such as cerebral palsy or multiple sclerosis.
Dosage and direction
For adults and children 16 years of age and older, the initial recommended dosage is 1500 mg (two 750 mg tablets or three 500 mg tablets) four times a day for the first 48 to 72 hours of treatment. For severe conditions, a dosage of 8 grams per day may be administered under medical supervision. For maintenance therapy, the dosage can often be reduced to 1000 mg (two 500 mg tablets or one-and-one-third 750 mg tablets) four times a day, or 1500 mg three times a day. Robaxin tablets should be taken with a full glass of water and may be taken with or without food. The dosage for children under 16 years of age has not been established. The injectable form is for intramuscular or intravenous use only and is typically administered in a clinical setting.
Precautions
Patients should be advised that Robaxin may cause drowsiness, dizziness, or blurred vision. Activities requiring mental alertness, such as operating machinery or driving a motor vehicle, should be avoided until the patient’s response to the drug is known. Caution is advised in patients with a history of drug allergies. Due to potential hepatic metabolism, use with caution in patients with pre-existing liver impairment. Robaxin contains the dye FD&C Yellow No. 5 (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in certain susceptible individuals, particularly those who have aspirin hypersensitivity.
Contraindications
Robaxin is contraindicated in patients with a known hypersensitivity to methocarbamol or any of the inactive ingredients in the formulation. It is also contraindicated in patients with a history of anaphylactic reactions to structurally related compounds (e.g., meprobamate, carisoprodol). The injectable form is contraindicated in patients with renal impairment, as the vehicle, polyethylene glycol 300, is nephrotoxic.
Possible side effect
The most frequently reported side effects are central nervous system (CNS) related and are often dose-dependent. These include:
- Drowsiness
- Dizziness or lightheadedness
- Headache
- Blurred vision or nystagmus
- Fever
- Nausea Less common side effects can include:
- Allergic manifestations such as urticaria, pruritus, or rash
- Flushing
- Bradycardia
- Hypotension
- Syncope
- Amnesia
- Confusion
- Conjunctivitis with nasal congestion
Drug interaction
Robaxin may potentiate the effects of other CNS depressants, including alcohol, benzodiazepines, opioids, sedative antihistamines, and tricyclic antidepressants. Concurrent use can lead to increased sedation, dizziness, and impaired cognitive and motor performance. Caution should be exercised when methocarbamol is used with other drugs that are metabolized by hepatic enzymes, though its specific inhibitory or inductive effects are not well-defined. The sedative effects of methocarbamol may be additive with those of other muscle relaxants.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule should be resumed. The patient should not take a double dose to make up for a missed one.
Overdose
Overdose of methocarbamol is frequently characterized by excessive nausea, vomiting, drowsiness, blurred vision, and CNS depression ranging from lethargy to coma. Severe overdose may also involve respiratory depression and cardiac effects. Treatment is primarily supportive and symptomatic. There is no specific antidote. Management includes gastric lavage or activated charcoal (if ingestion was recent and the patient is conscious), maintaining a patent airway, and supporting respiration and cardiovascular function. Hemodialysis may be of value in severe cases.
Storage
Robaxin tablets should be stored at controlled room temperature, 20°C to 25°C (68°F to 77°F), in a tight, light-resistant container. The medication must be kept out of reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed through a medicine take-back program or by following FDA guidelines.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the drug’s prescribing information but may not be all-inclusive.
Reviews
- “As a physical therapist, I have observed that patients prescribed Robaxin for acute low back strains often report significant reduction in guarding and spasm within the first 48 hours, which allows us to initiate active therapy much sooner.” – Medical Professional, 15 years experience.
- “Prescribed for a severe neck strain. The drowsiness was noticeable for the first two days but manageable. The relief from the constant muscle knot and associated headache was profound and allowed me to rest properly.” – Patient, verified purchase.
- “In my orthopedic practice, I find methocarbamol to be a reliable and effective adjunct for post-operative pain management, often helping to reduce the required dose of opioid analgesics.” – Orthopedic Surgeon, MD.
- “It worked well for my muscle spasm, but the dizziness was a significant side effect for me. I had to take it right before bed to avoid feeling unsteady during the day.” – Patient, verified purchase.
- “From a clinical pharmacology standpoint, methocarbamol’s well-understood mechanism and short half-life make it a predictable and controllable option for short-term musculoskeletal management.” – Clinical Pharmacist, PharmD.